To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
Clinical trial NCT04659070 · UNKNOWN
Trial details
- NCT number
- NCT04659070
- Sponsor
- Hanlim Pharm. Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2022-05-19
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.